|
The MCLC
The Mantle Cell Lymphoma Consortium (MCLC) was formed in January 2005 by the Lymphoma Research Foundation and is composed of 100 laboratory and clinical scientists from North America and Europe focusing their research efforts on mantle cell lymphoma. The Consortium is a program of the Lymphoma Research Foundation designed to accelerate the pace of research in mantle cell lymphoma. Our goal is to identify effective and curative treatment strategies for mantle cell lymphoma by funding innovative clinical studies.
The most recent meeting of the MCLC took place in March 2007 in Chicago. To read about the exciting developments in MCL research, including improved survival for patients, click here. To order a copy of the workshop report click here.
LRF Announces a new Resource for MCL Researchers
LRF, in collaboration with ATCC, has recently created a Mantle Cell Lymphoma Cell Bank. To read more about the Cell Bank, click here.
Researcher Profiles - At the Cutting Edge!
 With funding from LRF, Louis Staudt, MD, PhD, (National Cancer Institute) has been investigating the use of molecular techniques to profile lymphoma in an attempt to more accurately predict a patient's survival.
Click here to read more about Dr. Staudt's research.
Research in Focus: Zooming in on Mantle Cell
During the last three years, LRF has made an enormous investment in MCL research as well as forming the MCL Consortium. You can now read about the tremendous progress made in our new publication, entitled Research In Focus: Mantle Cell Lymphoma. This first issue focuses on the work of six of the MCL researchers that LRF has been funding. It also profiles three individuals who are living with this orphan disease whose lives have been changed because of the treatment options that are now available due to the research progress that has occurred.
If you would like to receive a copy of this issue, please click here . We hope you enjoy it and look forward to your feedback!
|
